An Innovative Direction
"The Syracuse Cancer Research Institute is a charitable, educational and scientific organization whose major purpose is the performance of laboratory and clinical cancer research aimed toward the innovation of new, effective treatments for cancer and the dissemination of its scientific findings and discoveries to the medical profession, scientific community and cancer patients worldwide. The Institute makes available to the public detailed information on its activities, in particular to its development, clinical use and clinical results of the anticancer drug hydrazine sulfate. Established in 1966, the Institute is a not-for-profit, tax-exempt organization and is wholly dependent for its funding on contributions from the public--from foundations, business and individuals. All gifts to the Institute are tax-deductible to the extent allowed by law."
The Elwood Fund
Elwood was a beloved seventeen-year-old cat who passed away June 16, 2005, of kidney failure. A sleek, short-hair female cat, Elwood made medical history and was responsible for the betterment of thousands of cats and dogs around the world. In 1997 Elwood had part of her stomach removed at Cornell University Veterinary Hospital for cancer; however, the edges sewn together were full of cancer and she was not expected to live long. She returned to the clinic six weeks later emaciated. She was placed on a course of chemotherapy to be given every three weeks and on daily hydrazine sulfate, an anticancer drug developed by the Syracuse Cancer Research Institute, and was given a prognosis of “two to five months.” The chemotherapy was discontinued after the second course because of side effects, and Elwood was maintained only on daily hydrazine sulfate. After the chemotherapy was discontinued, Elwood began to nibble, then eat voraciously. Until then, the longest-lived cat on record with her disease was one year. After one year, Elwood had regained all her lost weight, having been maintained only on daily hydrazine sulfate (and a steroid), and visited the clinic every six months for the next eight years. Word of her recovery spread throughout the nation, as a result of which thousands of cats and dogs were placed on hydrazine sulfate, many of whom were reported to have recovered completely.
The Syracuse Cancer Research Institute has established the Elwood Fund, dedicated to the beneficial treatment of small animals with terminal disease, to the dissemination of information to veterinarians and to owners of cats and dogs in regard to the therapy of these animals and to sponsership of new vetenary studies of animals facing various end-stage disease. Those wishing to contribute to the Elwood Fund are asked to send tax-deductible contributions to the Syracuse Cancer Research Institute, Elwood Fund, 600 E. Genesee Street, Syracuse, NY 13202. All contributions will be acknowledged.